BIOHIT HEALTHCARE LIMITED - Period Ending 2019-12-31

BIOHIT HEALTHCARE LIMITED - Period Ending 2019-12-31


BIOHIT HEALTHCARE LIMITED 06751724 false 2019-01-01 2019-12-31 2019-12-31 The principal activity of the company is sale of diagnostic tests and health products. Digita Accounts Production Advanced 6.26.9041.0 Software true 06751724 2019-01-01 2019-12-31 06751724 2019-12-31 06751724 bus:Director3 1 2019-12-31 06751724 core:RetainedEarningsAccumulatedLosses 2019-12-31 06751724 core:ShareCapital 2019-12-31 06751724 core:CurrentFinancialInstruments 2019-12-31 06751724 core:CurrentFinancialInstruments core:WithinOneYear 2019-12-31 06751724 core:FurnitureFittings 2019-12-31 06751724 core:OfficeEquipment 2019-12-31 06751724 core:PlantMachinery 2019-12-31 06751724 bus:SmallEntities 2019-01-01 2019-12-31 06751724 bus:Audited 2019-01-01 2019-12-31 06751724 bus:FullAccounts 2019-01-01 2019-12-31 06751724 bus:SmallCompaniesRegimeForAccounts 2019-01-01 2019-12-31 06751724 bus:RegisteredOffice 2019-01-01 2019-12-31 06751724 bus:Director2 2019-01-01 2019-12-31 06751724 bus:Director3 2019-01-01 2019-12-31 06751724 bus:Director3 1 2019-01-01 2019-12-31 06751724 bus:PrivateLimitedCompanyLtd 2019-01-01 2019-12-31 06751724 core:ComputerEquipment 2019-01-01 2019-12-31 06751724 core:FurnitureFittings 2019-01-01 2019-12-31 06751724 core:OfficeEquipment 2019-01-01 2019-12-31 06751724 core:PlantMachinery 2019-01-01 2019-12-31 06751724 countries:AllCountries 2019-01-01 2019-12-31 06751724 2018-12-31 06751724 core:FurnitureFittings 2018-12-31 06751724 core:OfficeEquipment 2018-12-31 06751724 core:PlantMachinery 2018-12-31 06751724 2018-01-01 2018-12-31 06751724 2018-12-31 06751724 core:RetainedEarningsAccumulatedLosses 2018-12-31 06751724 core:ShareCapital 2018-12-31 06751724 core:CurrentFinancialInstruments 2018-12-31 06751724 core:CurrentFinancialInstruments core:WithinOneYear 2018-12-31 06751724 core:FurnitureFittings 2018-12-31 06751724 core:OfficeEquipment 2018-12-31 06751724 core:PlantMachinery 2018-12-31 iso4217:GBP xbrli:pure

Registration number: 06751724

BIOHIT HEALTHCARE LIMITED

Annual Report and Financial Statements

for the Year Ended 31 December 2019

 

BIOHIT HEALTHCARE LIMITED

Contents

Company Information

1

Directors' Report

2

Balance Sheet

3 to 4

Notes to the Financial Statements

5 to 10

 

BIOHIT HEALTHCARE LIMITED

Company Information

Directors

Mr S Korpela

Mr G Johnson

Registered office

Pioneer House Pioneer Business Park
North Road
Ellesmere Port
Cheshire
CH65 1AD

 

Auditors

PENNINGTON WILLIAMS
Chartered Accountants and Statutory Auditors
Stanhope House
Mark Rake
Bromborough
Wirral
Merseyside
CH62 2DN

 

BIOHIT HEALTHCARE LIMITED

Directors' Report for the Year Ended 31 December 2019

The directors present their report and the financial statements for the year ended 31 December 2019.

Directors of the company

The directors who held office during the year were as follows:

Mr S Korpela

Mr G Johnson

Going concern

The directors have considered the impact on trade in relation to current global crisis of Corona virus and feel the company will continue for the foreseeable future and so continue to prepare the accounts on a going concern basis. Although the company will suffer a loss on sales in the first half of the next financial year, the directors have a reasonable expectation that these sales will return and the company has sufficient resources along with the continuing support of its parent company to be a going concern.

Disclosure of information to the auditors

Each director has taken steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditors are unaware.

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved by the Board on 24 September 2020 and signed on its behalf by:

.........................................
Mr G Johnson
Director

 

BIOHIT HEALTHCARE LIMITED

(Registration number: 06751724)
Balance Sheet as at 31 December 2019

Note

2019
£

2018
£

Fixed assets

 

Tangible assets

4

13,705

15,985

Current assets

 

Stocks

5

181,069

86,179

Debtors

6

297,732

206,263

Cash at bank and in hand

 

79,592

260,213

 

558,393

552,655

Creditors: Amounts falling due within one year

7

(422,398)

(235,274)

Net current assets

 

135,995

317,381

Total assets less current liabilities

 

149,700

333,366

Provisions for liabilities

(2,604)

(3,037)

Net assets

 

147,096

330,329

Capital and reserves

 

Called up share capital

1

1

Profit and loss account

147,095

330,328

Total equity

 

147,096

330,329

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

 

BIOHIT HEALTHCARE LIMITED

(Registration number: 06751724)
Balance Sheet as at 31 December 2019

Approved and authorised by the Board on 24 September 2020 and signed on its behalf by:
 

.........................................

Mr S Korpela
Director

.........................................

Mr G Johnson
Director

 

BIOHIT HEALTHCARE LIMITED

Notes to the Financial Statements for the Year Ended 31 December 2019

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Pioneer House Pioneer Business Park
North Road
Ellesmere Port
Cheshire
CH65 1AD

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Audit report

The Independent Auditor's Report was unqualified. We draw attention to the directors’ report in the financial statements that describes the director’s consideration of going concern. Our opinion is not qualified in respect of this matter. The name of the Senior Statutory Auditor who signed the audit report on 6 October 2020 was David Hunter FCA, who signed for and on behalf of PENNINGTON WILLIAMS.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

BIOHIT HEALTHCARE LIMITED

Notes to the Financial Statements for the Year Ended 31 December 2019

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant & Machinery

25% Reducing Balance

Fixtures & Fittings

25% Reducing Balance

Computer Equipment

33% Cost

Office Equipment

25% Reducing Balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

BIOHIT HEALTHCARE LIMITED

Notes to the Financial Statements for the Year Ended 31 December 2019

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

BIOHIT HEALTHCARE LIMITED

Notes to the Financial Statements for the Year Ended 31 December 2019

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 6 (2018 - 4).

 

BIOHIT HEALTHCARE LIMITED

Notes to the Financial Statements for the Year Ended 31 December 2019

4

Tangible assets

Fixtures and fittings
£

Plant and machinery
£

Office equipment
£

Total
£

Cost or valuation

At 1 January 2019

482

31,707

19,667

51,856

Additions

-

1,492

2,987

4,479

At 31 December 2019

482

33,199

22,654

56,335

Depreciation

At 1 January 2019

337

19,052

16,483

35,872

Charge for the year

36

3,537

3,185

6,758

At 31 December 2019

373

22,589

19,668

42,630

Carrying amount

At 31 December 2019

109

10,610

2,986

13,705

At 31 December 2018

145

12,656

3,184

15,985

5

Stocks

2019
£

2018
£

Other inventories

181,069

86,179

6

Debtors

2019
£

2018
£

Trade debtors

279,357

197,179

Prepayments

8,906

7,914

Other debtors

9,469

1,170

297,732

206,263

 

BIOHIT HEALTHCARE LIMITED

Notes to the Financial Statements for the Year Ended 31 December 2019

7

Creditors

Creditors: amounts falling due within one year

2019
£

2018
£

Due within one year

Trade creditors

83,390

50,729

Amounts owed to group undertakings and undertakings in which the company has a participating interest

190,002

11,787

Taxation and social security

96,269

71,448

Accruals and deferred income

24,800

23,780

Other creditors

27,937

77,530

422,398

235,274

8

Related party transactions

Transactions with directors

2019

Advances to directors
£

At 31 December 2019
£

Mr G Johnson

The following amounts have been advanced to the director, no interest has been charged on the outstanding balance

8,299

8,299